Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Karl Martin Klein, MD, PhD
Habilitation, Philipps University Marburg, GermanyDoctor of Philosophy, The University of Melbourne, Australia
Dr. med. (MD), Philipps University Marburg, Germany
Areas of Research
Genetics of Epilepsy
Our lab focuses on the genetics of epilepsy with a particular interested in multiplex families with epilepsy as well as adult and pediatric patients with epileptic encephalopathies. A backbone of our research is detailed phenotyping i.e. the detailed clinical characterization of each participating patient, which is followed by gene identification using next generation sequencing technology. The lab is also interested in the relevance of somatic mutations as a cause of epilepsy.
Our lab focuses on the genetics of epilepsy with a particular interested in multiplex families with epilepsy as well as adult and pediatric patients with epileptic encephalopathies. A backbone of our research is detailed phenotyping i.e. the detailed clinical characterization of each participating patient, which is followed by gene identification using next generation sequencing technology. The lab is also interested in the relevance of somatic mutations as a cause of epilepsy.
Precision medicine in epilepsy
The lab has strong interest in precision medicine not only in patients with monogenic causes of epilepsy but also in patients with complex inheritance. Dr. Klein coordinates an international consortium (RAISE-GENIC, funded by the ERA PerMed Cofound) which aims to develop tools that help physicians to select the anti-seizure drug with the best chance of success. This collaborative effort involves additional PIs at the University of Calgary (Dr. Colin Josephson) and three European countries (Germany, Finland, Belgium) and uses big data strategies to integrate clinical data, raw EEG and raw MRI data as well as exome sequencing data.
The lab has strong interest in precision medicine not only in patients with monogenic causes of epilepsy but also in patients with complex inheritance. Dr. Klein coordinates an international consortium (RAISE-GENIC, funded by the ERA PerMed Cofound) which aims to develop tools that help physicians to select the anti-seizure drug with the best chance of success. This collaborative effort involves additional PIs at the University of Calgary (Dr. Colin Josephson) and three European countries (Germany, Finland, Belgium) and uses big data strategies to integrate clinical data, raw EEG and raw MRI data as well as exome sequencing data.
Supervising degrees
Neuroscience - Masters: Accepting Inquiries
Neuroscience - Doctoral: Accepting Inquiries
Community Health Sciences - Masters: Accepting Inquiries
Community Health Sciences - Doctoral: Accepting Inquiries
Contact this supervisor
Complete the following form if you are interested in working with this supervisor for your Graduate Program. All fields are required, unless indicated otherwise.